Using midodrine to accelerate weaning of intravenous vasopressors in acute spinal cord injured patients admitted to the intensive care unit: A retrospective study of 28 patients
- 9 September 2025
- journal article
- Published by Taylor & Francis in The Journal of Spinal Cord Medicine
- p. 1-8
Abstract
A retrospective study with a crossover design. Maintaining mean arterial pressure (MAP) is crucial in the early management of SCI, yet the role of oral midodrine in this setting remains unclear. This study evaluates whether midodrine facilitates IV vasopressor weaning within 24 hours of initiation. The study was conducted at a Level 1 trauma center. A cohort of 28 patients was analyzed. MAP levels and IV vasopressor dosages were recorded 24 hours before and after midodrine initiation. The primary outcome was reduced IV vasopressor use while maintaining MAP targets. Midodrine was started on average 4.0±1.9 days after initiation of intravenous vasopressor therapy. Twenty-two individuals (78.6%) received less intravenous vasopressors during the 24-hour period after initiation of midodrine. Mean MAP remained similar 24 hours before vs. after initiation of midodrine (90.4±3.3 vs. 88.6±5.1 mm Hg). Earlier introduction of midodrine was significantly related to more rapid weaning and reduced total duration of intravenous vasopressor therapy. Initiating oral midodrine in the ICU within 7 days of a traumatic SCI resulted in a rapid decrease in intravenous vasopressor requirements in close to 80% of people while maintaining MAP targets, therefore supporting the potential of midodrine to accelerate the weaning of intravenous vasopressors.Keywords
Funding Information
- Fonds de Recherche du Québec - Santé Québec - Santé
- Medtronic Canada
This publication has 13 references indexed in Scilit:
- Oral Midodrine as an Adjunct in Rapid Weaning of Intravenous Vasopressor Support in Spinal Cord InjuryAsian Journal of Neurosurgery, 2023
- Letter to the Editor: “Midodrine to liberate ICU patients from intravenous vasopressors: Another negative fixed-dose trial”Journal of Critical Care, 2022
- Midodrine administration during critical illness: fixed-dose or titrate to response?Intensive Care Medicine, 2020
- Changes in Pressure, Hemodynamics, and Metabolism within the Spinal Cord during the First 7 Days after Injury Using a Porcine ModelJournal of Neurotrauma, 2017
- Traumatic spinal cord injuryNature Reviews Disease Primers, 2017
- Higher Mean Arterial Pressure Values Correlate with Neurologic Improvement in Patients with Initially Complete Spinal Cord InjuriesWorld Neurosurgery, 2016
- Midodrine for the weaning of vasopressor infusionsJournal of Clinical Pharmacy and Therapeutics, 2016
- Medical and Surgical Management after Spinal Cord Injury: Vasopressor Usage, Early Surgerys, and ComplicationsJournal of Neurotrauma, 2014
- A Systematic Review of the Management of Orthostatic Hypotension After Spinal Cord InjuryArchives of Physical Medicine and Rehabilitation, 2009
- Vasopressin Mediates α1-Adrenergic Stimulation of Adrenocorticotropin Secretion*Endocrinology, 1990